Dynamics of histone lysine methylation: structures of methyl writers and erasers.

Department of Biochemistry, Emory University School of Medicine, 1510 Clifton Road, Atlanta, Georgia 30322, USA.
Fortschritte der Arzneimittelforschung. Progress in drug research. Progrès des recherches pharmaceutiques 01/2011; 67:107-24. DOI: 10.1007/978-3-7643-8989-5_6
Source: PubMed

ABSTRACT In Eukarya, the packaging of DNA into chromatin provides a barrier that allows for regulation of access to the genome. Chromatin is refractory to processes acting on DNA. ATP-dependent chromatin remodeling machines and histone-modifying complexes can overcome this barrier (or strengthen it in silencing processes). Both components of chromatin (DNA and histones) are subject to postsynthetic covalent modifications, including methylation of lysines (the focus of this chapter). These lysine marks are generated by a host of histone lysine methyltransferases (writers) and can be removed by histone lysine demethylases (erasers). Importantly, epigenetic modifications impact chromatin structure directly or can be read by effector regulatory modules. Here, we summarize current knowledge on structural and functional properties of various histone lysine methyltransfereases and demethylases, with emphasis on their importance as druggable targets.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: There are more than 100 different biophenols reported in olive samples. This chapter covers the chemistry, pharmacodynamics, pharmacokinetics, posology, adverse effects, and potential drug interactions of olives and major olive biophenols (OBP). Major biophenols detected in olive samples include hydroxytyrosol, tyrosol and their secoiridoid derivatives (oleuropein, oleuropein aglycone, and elenolic acid dialdehydes), verbascoside, lignans, and flavonoids. By far the majority of reports on the chemistry of OBP pertain to their ability to function as antioxidants, but other bioactivities include binding to lipids, proteins, carbohydrates, and nucleic acids. The majority of pharmacological studies have focused on just four compounds hydroxytyrosol, tyrosol, oleuropein, and verbascoside. Reported pharmacological properties include antioxidant, anti-inflammatory, cardiovascular, immunomodulatory, gastrointestinal, respiratory, autonomic, central nervous system, antimicrobial, anticancer and chemopreventive. While OBP are generally regarded as safe, further studies on potential adverse reactions may be required to demonstrate the safety of supplements with elevated levels of compounds.
    Advances in Molecular Toxicology, Edited by James C. Fishbein, 01/2012: pages 195-242; Elsevier.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Isoflavones (IF) such as genistein are cancer preventive phytochemicals found in soy and other legumes. Epidemiological studies point to a reduced risk for hormone‑dependent cancers in populations following a typical Asian diet rich in soy products. IF act as phytoestrogens and prevent tumorigenesis in rodent models by a broad spectrum of bioactivities. During the past 10 years, IF were shown to target all major epigenetic mechanisms regulating gene expression, including DNA methylation, histone modifications controlling chromatin accessibility, and non-coding RNAs. These effects have been suggested to contribute to cancer preventive potential in in vitro and in vivo studies, affecting several key processes such as DNA repair, cell signaling cascades including Wnt-signaling, induction of apoptosis, cell cycle progression, cell proliferation, migration and invasion, epithelial-mesenchymal transition (EMT), metastasis formation and development of drug-resistance. We here summarize the state-of-the-art of IF affecting the epigenome in major hormone-dependent, urogenital, and gastrointestinal tumor types and in in vivo studies on anti-cancer treatment or developmental aspects, and short-term intervention studies in adults. These data, while often requiring replication, suggest that epigenetic gene regulation represents an important novel target of IF and should be taken into consideration when evaluating the cancer preventive potential of IF in humans.
    Nutrients 10/2014; 6(10):4218-4272. DOI:10.3390/nu6104218 · 3.15 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A major biomedical advance from recent years was the finding that gene expression and phenotypic traits may be shaped by potentially reversible and heritable modifications that occur without altering the sequence of the nucleotides, and became known as epigenetic changes. The term 'epigenetics' dates back to the 1940s, when it was first used in context of cellular differentiation decisions that are made during development. Since then, our understanding of epigenetic modifications that govern development and disease expanded considerably. The contribution of epigenetic changes to shaping phenotypes brings at least two major clinically relevant benefits. One of these, stemming from the reversibility of epigenetic changes, involves the possibility to therapeutically revert epigenetic marks to re-establish prior gene expression patterns. The strength and the potential of this strategy are illustrated by the first four epigenetic drugs that were approved in recent years and by the additional candidates that are at various stages in preclinical studies and clinical trials. The second particularity is the finding that epigenetic changes precede the appearance of histopathological modifications. This has the potential to facilitate the emergence of epigenetic biomarkers, some of which already entered the clinical arena, catalysing a major shift in prophylactic and therapeutic strategies, and promising to fill a decades-old gap in preventive medicine.
    International Journal of Clinical Practice 05/2014; 68(7). DOI:10.1111/ijcp.12436 · 2.54 Impact Factor


Available from